Evidence map›Paper›PMID 29348731›Full record

ArticleJournal of risk research2019

Problems with precaution: the transfusion medicine experience.

Kumanan Wilson, Katherine M Atkinson, Dean A Fergusson, Adalsteinn Brown, Alan Forster, Malia S Q Murphy, Alan T Tinmouth, Jennifer Keelan

Abstract read
In one paragraph

Article in Journal of risk research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Transfusion medicine: Overtime paradigm changes and emerging paradoxes.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2020
    Article
  4. Neuroethics for Fantasyland or for the Clinic? The Limitations of Speculative Ethics.Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kumanan WilsonClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Katherine M AtkinsonClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Dean A FergussonClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Adalsteinn BrownInstitute for Health Policy, Management & Evaluation, University of Toronto, Toronto, Canada.
Alan ForsterClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Malia S Q MurphyClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Alan T TinmouthClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
Jennifer KeelanDalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Funding

CIHR 119492-1
6 · The paper itself

Abstract

The precautionary principle is a dominant paradigm governing risk-based decision-making. Today, there are increasing pressures to re-examine aggressive precautionary approaches, and to assess how the principle should be applied in the modern system. In this paper, we examined three key applications of precautionary approaches in the field of transfusion medicine to provide insight into the risks and benefits of these approaches. The three case studies examined were the donor deferral policies to safeguard against transfusion transmission of human immunodeficiency virus, variant Creutzfeldt-Jacob disease, and, lastly, xenotropic murine leukemia virus-related virus. Characterization of precautionary applications was conducted using an embedded case study design. Our findings indicate that transfusion transmission mitigation strategies have become increasingly aggressive in the face of theoretical risks. In contrast, the review processes for implementation and reversal of precautionary policies have been slow, and historical donor deferral policies are still in place today. Application of precautionary approaches has proved challenging with both benefits and pitfalls. In light of emerging threats to the blood system, policy-makers should consider the implementation of frameworks to guide the appropriate application of precaution in transfusion medicine in the future.

Indexed as

Blood transfusiondonor exclusionprecautionary principlerisk–benefit assessment

Identifiers

PMID29348731
PMCPMC5770215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.